Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather to chart the course for 2025 and take stock of the landscape, both financial and political.
Endpoints News – Biotech and pharma business news, with a focus …
A Florida-based car dealer has joined mounting litigation against Eli Lilly, Novo Nordisk and Sanofi over what it calls the “exorbitant” price of insulin.
Endpoints 11 2024 - events.endpts.com
We’re back with this year’s selection of the top eleven most promising biotechs. They’re taking big swings with cutting-edge science and proven leadership, and the industry is watching to see if they succeed — or fail. Either way, they’ll be bellwethers for where biotech is heading. Join a select group of industry leaders for this year’s awards gala in Downtown Boston for an ...
UniQure stock doubles after FDA meeting on Huntington’s disease
Dec 10, 2024 · Dutch-based uniQure saw its stock rise by more than 120% on Tuesday after it disclosed that it is 'in alignment' with the FDA on using the accelerated approval pathway for its experimental ...
Clinical Trials Day 2024
Dec 17, 2024 · Join Endpoints for a series of conversations on the latest trends in clinical trials in the US and abroad, the regulatory environment, and how expectations from the industry and beyond are shifting the trial strategies of the future.
Special report 2024: Meet 20 women breaking new ground in …
Oct 7, 2024 · Dedicated to the memory of Natalie Grover, who co-created the Women in Biopharma R&D special report while she was a reporter at Endpoints from 2018-2020. Natalie passed away earlier ...
Novartis buys Kate Therapeutics in $1.1B deal, eyes more bolt-on …
Nov 21, 2024 · Novartis is acquiring Kate Therapeutics for $1.1 billion, focusing on gene therapy and neuroscience. CEO Vas Narasimhan and CFO Harry Kirsch indicate future M&A deals will likely stay under $3 ...
News – Endpoints News
reset password. We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours. email
Novo Nordisk asks FDA to prohibit semaglutide compounding, …
Oct 23, 2024 · Novo Nordisk has asked the FDA to prohibit the compounding of semaglutide, ramping up the company’s fight against pharmacies distributing their own versions of the …
Gilead pulls Trodelvy’s accelerated label in bladder cancer after …
Oct 18, 2024 · Gilead is withdrawing the accelerated approval for its blockbuster antibody-drug conjugate Trodelvy for bladder cancer after it failed to improve survival odds for patients in a Phase 3 study ...